These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 23464581)

  • 1. Molecular and serological markers of Leishmania donovani infection in healthy individuals from endemic areas of Bihar, India.
    Srivastava P; Gidwani K; Picado A; Van der Auwera G; Tiwary P; Ostyn B; Dujardin JC; Boelaert M; Sundar S
    Trop Med Int Health; 2013 May; 18(5):548-54. PubMed ID: 23464581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serological and Molecular Analysis of
    Kaushal H; Bhattacharya SK; Verma S; Salotra P
    Am J Trop Med Hyg; 2017 Jun; 96(6):1448-1455. PubMed ID: 28719266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PCR and direct agglutination as Leishmania infection markers among healthy Nepalese subjects living in areas endemic for Kala-Azar.
    Bhattarai NR; Van der Auwera G; Khanal B; De Doncker S; Rijal S; Das ML; Uranw S; Ostyn B; Praet N; Speybroeck N; Picado A; Davies C; Boelaert M; Dujardin JC
    Trop Med Int Health; 2009 Apr; 14(4):404-11. PubMed ID: 19228350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Asymptomatic infection of visceral leishmaniasis in hyperendemic areas of Vaishali district, Bihar, India: a challenge to kala-azar elimination programmes.
    Das VN; Siddiqui NA; Verma RB; Topno RK; Singh D; Das S; Ranjan A; Pandey K; Kumar N; Das P
    Trans R Soc Trop Med Hyg; 2011 Nov; 105(11):661-6. PubMed ID: 21945327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Latent infection with Leishmania donovani in highly endemic villages in Bihar, India.
    Hasker E; Kansal S; Malaviya P; Gidwani K; Picado A; Singh RP; Chourasia A; Singh AK; Shankar R; Menten J; Wilson ME; Boelaert M; Sundar S
    PLoS Negl Trop Dis; 2013; 7(2):e2053. PubMed ID: 23459501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relevance of direct agglutination test in seroepidemiological survey of Kala-azar in epidemic foci of Bihar.
    Sharma MC; Bimal S; Ranjan A; Das VN; Gupta AK; Kumar N; Kar SK
    J Commun Dis; 2000 Jun; 32(2):117-22. PubMed ID: 11198396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of asymptomatic Leishmania infection in Bangladesh by antibody and antigen diagnostic tools shows an association with post-kala-azar dermal leishmaniasis (PKDL) patients.
    Owen SI; Hossain F; Ghosh P; Chowdhury R; Hossain MS; Jewell C; Cruz I; Picado A; Mondal D; Adams ER
    Parasit Vectors; 2021 Feb; 14(1):111. PubMed ID: 33597000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serological markers for leishmania donovani infection in Nepal: Agreement between direct agglutination test and rK39 ELISA.
    Khanal B; Rijal S; Ostyn B; Picado A; Gidwani K; Menten J; Jacquet D; Lejon V; Chappuis F; Boelaert M
    Trop Med Int Health; 2010 Nov; 15(11):1390-4. PubMed ID: 21998875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and determinants of asymptomatic Leishmania infection in HIV-infected individuals living within visceral leishmaniasis endemic areas of Bihar, India.
    Mahajan R; Owen SI; Kumar S; Pandey K; Kazmi S; Kumar V; Adams ER; Harshana A; Burza S
    PLoS Negl Trop Dis; 2022 Aug; 16(8):e0010718. PubMed ID: 36040931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative evaluation of serological tests in Indian kala-azar.
    Sinha R; Sehgal S
    J Trop Med Hyg; 1994 Dec; 97(6):333-40. PubMed ID: 7966534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determinants for progression from asymptomatic infection to symptomatic visceral leishmaniasis: A cohort study.
    Chakravarty J; Hasker E; Kansal S; Singh OP; Malaviya P; Singh AK; Chourasia A; Singh T; Sudarshan M; Singh AP; Singh B; Singh RP; Ostyn B; Fakiola M; Picado A; Menten J; Blackwell JM; Wilson ME; Sacks D; Boelaert M; Sundar S
    PLoS Negl Trop Dis; 2019 Mar; 13(3):e0007216. PubMed ID: 30917114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sero-epidemiological study of kala-azar in a village of Varanasi district, India.
    Kumar R; Pai K; Kumar P; Pandey HP; Sundar S
    Trop Med Int Health; 2006 Jan; 11(1):41-8. PubMed ID: 16398754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of an improved method for the recombinant k 39 enzyme-linked immunosorbent assay to detect visceral leishmaniasis disease and infection in Bangladesh.
    Kurkjian KM; Vaz LE; Haque R; Cetre-Sossah C; Akhter S; Roy S; Steurer F; Amann J; Ali M; Chowdhury R; Wagatsuma Y; Williamson J; Crawford S; Breiman RF; Maguire JH; Bern C; Secor WE
    Clin Diagn Lab Immunol; 2005 Dec; 12(12):1410-5. PubMed ID: 16339064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of noninvasive markers to detect Leishmania infection in asymptomatic human immunodeficiency virus-infected patients.
    García-García JA; Martín-Sánchez J; Gállego M; Rivero-Román A; Camacho A; Riera C; Morillas-Márquez F; Vergara S; Macías J; Pineda JA
    J Clin Microbiol; 2006 Dec; 44(12):4455-8. PubMed ID: 17050814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conversion of asymptomatic infection to symptomatic visceral leishmaniasis: A study of possible immunological markers.
    Das VNR; Bimal S; Siddiqui NA; Kumar A; Pandey K; Sinha SK; Topno RK; Mahentesh V; Singh AK; Lal CS; Singh SK; Das P
    PLoS Negl Trop Dis; 2020 Jun; 14(6):e0008272. PubMed ID: 32555598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent advances in the diagnosis and treatment of kala-azar.
    Sundar S; Chakravarty J
    Natl Med J India; 2012; 25(2):85-9. PubMed ID: 22686715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative study of serologic tests for the diagnosis of asymptomatic visceral leishmaniasis in an endemic area.
    Romero HD; Silva Lde A; Silva-Vergara ML; Rodrigues V; Costa RT; Guimarães SF; Alecrim W; Moraes-Souza H; Prata A
    Am J Trop Med Hyg; 2009 Jul; 81(1):27-33. PubMed ID: 19556562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Presence of anti-Lepp12 antibody: a marker for diagnostic and prognostic evaluation of visceral leishmaniasis.
    Kumar D; Srividya G; Verma S; Singh R; Negi NS; Fragaki K; Kubar J; Salotra P
    Trans R Soc Trop Med Hyg; 2008 Feb; 102(2):167-71. PubMed ID: 18177681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Asymptomatic Leishmania infections in northern India: a threat for the elimination programme?
    Das S; Matlashewski G; Bhunia GS; Kesari S; Das P
    Trans R Soc Trop Med Hyg; 2014 Nov; 108(11):679-84. PubMed ID: 25205664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a species-specific PCR assay for detection of Leishmania donovani in clinical samples from patients with kala-azar and post-kala-azar dermal leishmaniasis.
    Salotra P; Sreenivas G; Pogue GP; Lee N; Nakhasi HL; Ramesh V; Negi NS
    J Clin Microbiol; 2001 Mar; 39(3):849-54. PubMed ID: 11230394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.